George Robinson Overview

  • Investor Type
  • Angel

  • Investments
  • 3

  • Portfolio
  • 2

  • Exits
  • 2

Exits

George Robinson General Information

Description

Mr. George Robinson is a Co-Founding Partner at Oxford Investment Consultants. He is also the Co-Founder and serves as a Partner at Sloane Robinson. He serves as Board Member at Organix. Mr. George serves as a Board Member at Truphone. He served as Board Member at Oxford PV and Bodle Technologies. Mr. George serves as a Board Member at Truphone.Prior to that he worked for 15 years in Asia, initially for John Swire and Sons in Hong Kong, Korea, and the Philippines, and then for Asian-based stockbroker WI Carr in Korea, Thailand, and Hong Kong where he was Director of Regional Research. He is an active investor in early-stage technology and biotech companies with a particular focus on Oxford spin-outs and is a founding Partner of Technikos, a private equity partnership that invests in spin-out companies from the Oxford Institute of Biomedical Engineering. He is an investor in a number of Oxford-based companies and a partner of Oxford Investments Consultants which advises the Oxford Technology and Innovations EIS Fund. He is an honorary fellow of Keble College, Oxford from where he graduated with an MA in Engineering Science and is a member of the Oxford University Endowment Investment Committee. He is an Angel Investor.

Contact Information

Year Founded
1991
Primary Investor Type
Angel (individual)
Primary Office
  • London
  • England, United Kingdom

George Robinson Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Navenio 21-Sep-2023 Later Stage VC 000.00 Enterprise Systems (Healthcare) Generating Revenue 000000 00000000
ONI 04-May-2016 0000 00000 00.000 Discovery Tools (Healthcare) Generating Revenue 000000 00000000
Adaptimmune Therapeutics 19-Sep-2014 00000 00000 00000 Other Commercial Services Generating Revenue/Not Profitable 000000 00000000

George Robinson Exits (2)

Company Name Exit Date Exit Type Exit Size
Adaptimmune Therapeutics 06-May-2015 IPO 00000
Adaptimmune Therapeutics 000000000 00000000

George Robinson Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

George Robinson Team (1)

Name Title Deals Funds Boards Office
George Robinson Angel Investor 00 0 0 London, United Kingdom

George Robinson Co-Investors (9)

Name With Exits Lead Partner Series Industry
G.K. Goh Holdings 1 0 Series chart Industry bar
Hostplus Superannuation Fund 0 0 Series chart Industry bar
IP Group 0 0 Series chart Industry bar
Oxford Science Enterprises 0 0 Series chart Industry bar
Oxford University Innovation 0 0 Series chart Industry bar